During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed the data supporting the 2 newer BTK ...

Veterinarians were able to catch the ray's cancer early, allowing her to "thrive" and also allowing experts to collect data to treat the rare cancer in the future.

A patient advocate for cancer clinical trials has said the bureaucracy hindering clinical trials in Ireland is “putting lives ...

A Cownose stingray at the Flordia Aquarium is being recognized as a part of the nationwide World Cancer Day celebration on ...

When Houston lost the Oilers, Bob McNair worked to bring the NFL back to town. And along the way became one of region's main ...

Venetoclax, a selective Bcl-2 inhibitor, has proven effective in chronic lymphocytic leukemia (CLL), but genetic mutations or ...

Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's ...

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

Panelists discuss how decisions to switch between Bruton tyrosine kinase (BTK) inhibitors are driven by multiple factors including intolerable toxicities, development of resistance mutations, disease ...

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in protein degradation therapies, has been ...

Stifel analysts increased the price target on Nurix Therapeutics Inc . (NASDAQ:NRIX) shares to $36.00, up from the previous target of $34.00, while reaffirming their Buy rating on the stock. The ...